Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Intralesional verapamil for the treatment of Peyronie's disease: a review

Abstract

Multiple treatment options have been used for Peyronie's disease (PD) including intralesional injection of the calcium antagonist verapamil. The use of verapamil is based on its capacity to alter fibroblast function at several levels, including cell proliferation, extracellular matrix protein synthesis and secretion, as well as collagen degradation. Consequently, calcium antagonists may have the capacity to slow, prevent, or even reverse plaque formation and the progression of PD. The multicenter international experience with intralesional verapamil injection suggests that the majority of men with PD that receive treatment demonstrate durable reduction in pain, decrease in curvature, and improved sexual function. We review the scientific rationale, published literature, clinical experience, and technique of intralesional injection of verapamil.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. de La Peyronie F . Sur quelques obstacles qui s'opposent a l'ejaculation naturelle de la semence Mem de l'Acad Roy de Chir 1743 1: 425–434

    Google Scholar 

  2. Abdel-Salam Y et al. Treatment of Peyronie's disease by extra corporeal shockwave therapy: evaluation of our preliminary results Journal of Urology 1997 13: 549–552

    Google Scholar 

  3. Bittard H, Schraub S, Bittard M . Treatment of Peyronie's disease by a combination of radiotherapy and surgery. Apropos of 51 cases Annales d Urologie 1988 22: 67–69

    CAS  PubMed  Google Scholar 

  4. Stojic M, Negrojevic M, Josic P, Stojic S . Conservative therapy of Peyronie's disease using vitamin E Medicinski Pregled 1987 40: 133–135

    CAS  PubMed  Google Scholar 

  5. Akkus E et al. Is colchicine effective in Peyronie's disease? A pilot study Urology 1994 44: 291–295

    Article  CAS  Google Scholar 

  6. Teloken C et al. Tamoxifen vs placebo in the treatment of Peyronie's disease Journal of Urology 1999 162: 2003–2005

    Article  CAS  Google Scholar 

  7. Carson CC . Potassium para-aminobenzoate for the treatment of Peyronie's disease: is it effective? Techniques in Urology 1997 3: 135–139

    CAS  PubMed  Google Scholar 

  8. Riedl CR et al. Iontophoresis for treatment of Peyronie's disease Journal of Urology 2000 163: 95–99

    Article  CAS  Google Scholar 

  9. Treffiletti et al. Iontophoresis in the conservative treatment of Peyronie's disease: preliminary experience Archivio Italiano di Urologia, Andrologia 1997 69: 323–327

    CAS  PubMed  Google Scholar 

  10. Gelbard MK, James K, Riach P, Dovey F . Collagenase vs placebo in the treatment of Peyronie's disease: a double-blind study Journal of Urology 1993 149: 56–58

    Article  CAS  Google Scholar 

  11. Cipollone G et al. Betamethasone vs placebo in Peyronie's disease Archivio Italiano di Urologia, Andrologia 1998 70: 165–168

    CAS  PubMed  Google Scholar 

  12. Primus G . Orgetein in the treatment of plastic induration of the penis (Peyronie's disease) International Urology and Nephrology 1993 25: 169–172

    CAS  PubMed  Google Scholar 

  13. Ahuja S et al. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease Journal of Andrology 1999 20: 444–448

    CAS  PubMed  Google Scholar 

  14. Levine LA . Treatment of Peyronie's disease with intralesional verapamil injection Journal of Urology 1997 158: 1395–1399

    Article  CAS  Google Scholar 

  15. Kelly RB . Pathways of protein secretion in eukaryotes Science 1985 230: 25–32

    Article  CAS  Google Scholar 

  16. Aggeler J, Frisch SM, Werb Z . Changes in cell shape correlate with collagenase gene expression in rabbit synovial fibroblasts Journal of Cell Biology 1984 98: 1662–1671

    Article  CAS  Google Scholar 

  17. Askey DB et al. The effect of weak electric fields and verapamil on exocytosis in human fibroblasts Journal of Cell Biology 1988 107: 336a abstract 1905

    Google Scholar 

  18. Lee RC, Ping JA . Calcium antagonists retard extracellular matrix production in connective tissue equivalent J Surg Res 1990 49: 463–466

    Article  CAS  Google Scholar 

  19. Kappas AM, Barsoum GH, Ortiz JB, Keighly MR . Prevention of peritoneal adhesions in rats with verapamil, hydrocortisone sodium succinate, and phosphatidylcholine European Journal of Surgery 1992 158: 33–35

    CAS  PubMed  Google Scholar 

  20. Steinleitner A, Kazensky C, Lambert H . Calcium channel blockade prevents postsurgical reformation of adnexal adhesions in rabbits Obstetrics and Gynecology 1989 74: 796–798

    CAS  PubMed  Google Scholar 

  21. Johnson H, Parham M, Davis E, Wise L . Preliminary study of the protective effect of the calcium channel blocker, nifedipine, on adriamycin-induced tissue injury J Invest Surg 1991 4: 313–322

    Article  Google Scholar 

  22. Lee RC, Doong H, Jellema AF . The response of burn scars to intralesional verapamil. Report of five cases Arch Surg 1994 129: 107–111

    Article  CAS  Google Scholar 

  23. Roth M, Eickelberg O, Kohler E, Erne P, Block LH . Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix Proc Natl Acad Sci 1996 93: 5478–5482

    Article  CAS  Google Scholar 

  24. Stetler-Stevenson WG . Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix Amer J Path 1996 148: 1345

    CAS  PubMed  Google Scholar 

  25. Wolf JS Jr, Soble JJ, Ratliff TL, Clayman RV . Ureteral cell cultures II. Collagen production and response to pharmacological agents J Urol 1996 156: 2067

    Article  CAS  Google Scholar 

  26. Rodler S, Roth M, Nauck M, Tamm M, Block LH . Ca(2+)-channel blockers modulate the expression of interleukin-6 and interleukin-8 genes in human vascular smooth muscle cells J Mol Cell Cardiol 1995 27: 2295

    Article  CAS  Google Scholar 

  27. Anderson MS, Shankey TV, Lubrano T, Mulhall JP . Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents International Journal of Impotence Research 2000 Suppl. 3 S25–S31

    Article  Google Scholar 

  28. Levine LA, Merrick PF, Lee RC . Intralesional verapamil injection for the treatment of Peyronie's disease J Urol 1994 151: 1522–1524

    Article  CAS  Google Scholar 

  29. Arena F . Clinical effects of verapamil in the treatment of Peyronie's disease Acta Biomed Ateneo Parmense 1995 66: 269–272

    CAS  PubMed  Google Scholar 

  30. Teloken C et al. Objective evaluation of non-surgical approach for Peyronie's disease J Urol 1996 155: 633A abstract 1290

    Google Scholar 

  31. Lasser A, Vandenberg TL, Vincent MJ, Hellstrom WJ . Intraplaque verapamil injection for treatment of Peyronie's disease Journal of the Louisiana State Medical Society 1998 150: 431–434

    CAS  PubMed  Google Scholar 

  32. Rehman J, Benet A, Melman A . Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study Urology 1998 51: 620–626

    Article  CAS  Google Scholar 

  33. Levine LA, Goldman KE . Updated experience with intralesional verapamil injection treatment for Peyronie's disease J Urol 2000 163: 170 abstract 751

    Google Scholar 

  34. Shadish WR, Cook TD, Campbell DT . Experimental and quasi-experimental designs for generalized causal inference Houghton-Mifflin: Boston 2002

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L A Levine.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Levine, L., Estrada, C. Intralesional verapamil for the treatment of Peyronie's disease: a review. Int J Impot Res 14, 324–328 (2002). https://doi.org/10.1038/sj.ijir.3900917

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3900917

Keywords

  • Peyronie's
  • disease
  • verapamil
  • intralesional injection

This article is cited by

Search

Quick links